The Bertarelli Foundation of Switzerland, co-chaired by Ernesto Bertarelli, M.B.A. ’93, has established the Bertarelli Foundation Health and Life Sciences Entrepreneurship Fund with a gift to Harvard Business School.
Author and activist Eve Ensler, who opened Radcliffe’s two-day conference “Who Decides? Gender, Medicine, and the Public’s Health,” read from her new memoir, “In the Body of the World.” The conference brought together physicians, policymakers, journalists, and academics to examine topics such as how we care for our health and respond to disease.
Annual dinner honors Harvard staff who became U.S. citizens with help from the Harvard Bridge Program and the Harvard Kennedy School’s Institute of Politics.
Harvard stem cell scientists have discovered that a recently approved medication for epilepsy might be a meaningful treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, a uniformly fatal neurodegenerative disorder.
Investigators at Harvard-affiliated Massachusetts General Hospital (MGH) may have found a way to solve a problem that has plagued ligand-mimicking integrin inhibitors, a group of drugs that have the potential to treat conditions ranging from heart attacks to cancer metastasis.
Harvard researchers have estimated that around 1 million children suffer from tuberculosis annually — twice the number previously thought to have the disease and three times the number of cases diagnosed every year.
Harvard University has announced 18 student-led teams as finalists in three deans’ innovation competitions focused on cultural entrepreneurship, health and life sciences, and design.
Harvard researchers have released the first study to show that the adverse effects of fried foods may vary depending on the genetic makeup of the individual.
Even the “healthy” fruit drinks that Americans sip are packed with the amount of sugar contained in six cookies. That love affair is making us sick.
Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University have discovered a way to build self-assembling cages made of DNA. The cages are the largest stand-alone DNA structures made to date, and one day may be able to deliver drugs or house tiny bioreactors or photonic devices inside the human body.
A novel approach to cancer immunotherapy — strategies designed to induce the immune system to attack cancer cells — may provide a new and cost-effective weapon against some of the most deadly tumors, including ovarian cancer and mesothelioma.
Researchers at the Broad Institute and Massachusetts General Hospital, both Harvard affiliates, have identified mutations in a gene that can reduce the risk of individuals developing type 2 diabetes. If a drug can be developed that mimics the protective effect of these mutations, it could open up new ways of preventing this devastating disease.
The first clinical trial of a drug intended to delay the onset of symptoms of Huntington’s disease (HD) reveals that high-dose treatment with the nutritional supplement creatine was safe and well tolerated by most study participants. Neuroimaging also showed a treatment-associated slowing of regional brain atrophy, evidence that creatine might slow the progression of presymptomatic HD.
Syrian refugees struggling in Lebanon are on the edge of catastrophe, according to a new report from the FXB Center for Health and Human Rights.
Harvard’s Wyss Institute has found a new DNA-based, super-resolution microscopy method that could simultaneously spot dozens of distinct types of biomolecules. This could potentially lead to new ways to diagnose disease, track its prognosis, or monitor the effectiveness of therapies at a cellular level.
Remnants of Neanderthal DNA in modern humans are associated with genes affecting type 2 diabetes, Crohn’s disease, lupus, biliary cirrhosis, and smoking behavior. They also concentrate in genes that influence skin and hair characteristics. At the same time, Neanderthal DNA is conspicuously low in regions of the X chromosome and testes-specific genes.
Researchers have created embryonic stem cells without an embryo. This discovery of a novel reprogramming method of adult cells, without introducing external genetic material, could dramatically shift stem cell research.
A group of Harvard Medical School students is using the viral success of tongue-in-cheek video on the spleen to promote science education, launching a contest for younger students to make organ-themed music videos.
The waterproof, light-activated glue developed by researchers at Harvard-affiliated Brigham and Women’s Hospital and Children’s Hospital Boston and their colleagues at MIT can successfully secure biodegradable patches to seal holes in a beating heart.
Using color-coded labels to mark healthier foods and then displaying them more prominently appears to have prompted customers to make more healthful long-term dining choices in their large hospital cafeteria, according to a report from Harvard-affiliated Massachusetts General Hospital
Ludwig Cancer Research, on behalf of its founder, Daniel K. Ludwig, has given Harvard Medical School $90 million to spur innovative scientific inquiry and discovery. According to the Ludwig announcement, this new financial support is among the largest private gifts ever for cancer research.
The healthiest diets cost about $1.50 more per day than the least healthy diets, according to new research from Harvard School of Public Health. The finding is based on the most comprehensive examination to date comparing prices of healthy foods and diet patterns against less healthy ones.
The annual “Giving Thanks” open house was an opportunity for members of the Harvard community to write notes of gratitude to fellow staff members and provide support for community programs.
A Massachusetts General Hospital-led research team of Harvard affiliates has identified an immune cell protein that is critical to setting off the body’s initial response against viral infection.
In the largest study of its kind, people who ate a daily handful of nuts were found to be 20 percent less likely to die from any cause over a 30-year period than those who didn’t consume nuts, say Harvard researchers.
A drug approved for the treatment of rheumatoid arthritis may also turn out to be the first targeted therapy for one of the most common forms of kidney disease, a condition that almost inevitably leads to kidney failure.
What’s behind the fascination with horror? A number of Harvard experts recently offered their insight into the genre’s powerful lure.
Two new books from Harvard Health Publications are aimed at people who have more than normal levels of anxiety and depression but fall short of clinical definitions.
A Harvard-backed initiative in Chile aims to reduce economic disparity through an early education health initiative supported by the Harvard Graduate School of Education and Harvard Medical School.
Experts in child health gathered at Harvard Medical School on Tuesday for a symposium on how genome biology is changing children’s health.
Targeted nanotherapy is the wave of the medical future, according to Omid Farokhzad, a Harvard Medical School and Brigham and Women’s Hospital researcher who has two nanoparticle-based therapies in clinical trials and a slew of ideas for new ways to put the tiny capsules to work for human health.
James E. Rothman, a 1976 Harvard alumnus, won a share of the 2013 Nobel Prize in physiology or medicine for work illuminating the internal machinery that cells use to transport molecules.
From the calming and relaxing properties of lavender, to the antiviral offerings of lemon balm the Harvard Countway Community Garden offers a wealth of ...
People who are married when diagnosed with cancer live longer than those who are not married. Married patients also tended to have cancers diagnosed at an earlier stage, according to Harvard researchers.
After the U.S. Centers for Disease Control and Prevention issued a report on the threat from drug-resistant bacteria, David Hooper, a physician at Massachusetts General Hospital and an authority on the subject, discussed the issues during a question-and-answer session.
Professor Howard Green stumbled across a skin transplant technique that involved growing keratinocytes into full skin layers, making him a pioneer in regenerative medicine.
Removing a woman’s healthy breasts might seem like a radical response to fears of breast cancer. But for women with genetic mutations that put them at high risk of developing the disease, it’s a step that can cut their vulnerability by 90 to 95 percent.
A team of researchers at the Wyss Institute has found a way to self-assemble complex structures out of gel “bricks” smaller than a grain of salt. The new method could help solve one of the major challenges in tissue engineering.
Jessica Meir, an assistant professor of anesthesia at Harvard Medical School and Massachusetts General Hospital, is the latest member of the Harvard community given a chance to head to space, joining moon-walkers and Hubble Space Telescope repairmen as she trains to become a NASA astronaut.
A cross-disciplinary team of Harvard scientists, engineers, and clinicians announced Sept. 6 that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer.
Thirty-one schoolteachers spent four days on campus last week at a workshop put together by Harvard’s regional centers and programs to provide background on the growing global water crisis.
An international scientific collaborative led by the Harvard Stem Cell Institute’s Kornelia Polyak has discovered why women who give birth in their early 20s are less likely to develop breast cancer than women who don’t, triggering a search for a way to confer this protective state on all women.
Scientists at Harvard-affiliated Dana-Farber Cancer Institute observed a strong and selective immune response in some patients who received several doses of a “personalized” tumor vaccine composed of their own inactivated leukemia cells combined with an immune stimulant.
About half of a small group of patients with fibromyalgia — a common syndrome that causes chronic pain and other symptoms — were found to have damage to nerve fibers in their skin and other evidence of a disease called small-fiber polyneuropathy.
The Nikon Imaging Center at Harvard Medical School is the largest light microscopy facility on the Longwood campus. The staff are busy transitioning the ...
Sixty men and women from across Harvard were honored for their outstanding work and service to the University’s mission at the annual Harvard Heroes event.
Specialists examines the country's obesity problem from several angles at an HMS-MGH forum.
H. Stephen Leff, an assistant professor of clinical psychology in the Department of Psychiatry at Harvard Medical School, has received the Carl Taube Award from the American Public Health Association.
Tucker Collins was S. Burt Wolbach Professor of Pathology and the Chief of Pathology at Boston Children’s Hospital. He passed away in 2007 at the age of 54 years due to an aggressive brain tumor.
Nothing about Joseph L. Henry was ordinary. In his academic career he excelled noticeably above others -- as a student, teacher, department chair, dean, board member, national policy adviser, and as a mentor to many health professionals and policy makers.